FDA accepts Cingulate's drug application for ADHD treatment CTx-1301

Go back to FDA accepts Cingulate's drug application for ADHD treatment CTx-1301
(NASDAQ: CING) Delayed: 5.38 -0.51 (8.66%)
Previous Close $5.89    52 Week High
Open $5.95    52 Week Low
Day High $5.95    P/E N/A 
Day Low $5.35    EPS
Volume 378,205       

(NASDAQ: CINGW) Delayed: 0.02 --0 (-0%)
Previous Close $0.02    52 Week High
Open $0.02    52 Week Low
Day High $0.02    P/E N/A 
Day Low $0.02    EPS
Volume 14,064